Sioulas, V D <br/><br/>
Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells?  [electronic resource] 

 -  Climacteric : the journal of the International Menopause Society  Apr 2012 
 - 181-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1473-0804 
<br/><br/><label>Standard No.: </label>10.3109/13697137.2011.604144  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Androstenedione--blood<br/>Cervix Uteri--metabolism<br/>Contraceptives, Oral, Synthetic--pharmacology<br/>Cross-Sectional Studies<br/>Epithelial Cells--metabolism<br/>Estradiol--pharmacology<br/>Estrogen Antagonists--pharmacology<br/>Estrogen Receptor Modulators--pharmacology<br/>Estrogens--pharmacology<br/>Female<br/>Humans<br/>Metaplasia--metabolism<br/>Middle Aged<br/>Norethindrone--analogs & derivatives<br/>Norethindrone Acetate<br/>Norpregnenes--pharmacology<br/>Papanicolaou Test<br/>Postmenopause--blood<br/>Raloxifene Hydrochloride--pharmacology<br/>Statistics, Nonparametric<br/>Vaginal Smears<br/>Vascular Endothelial Growth Factor A--drug effects